Correlation Of Microglial Activation With White Matter Changes In Dementia With Lewy Bodies
Nicolas NicastroiD, Elijah MakiD, Guy B. WilliamsiD, Ajenthan SurendranathaniD, William Richard Bevan-JonesiD, Luca PassamontiiD, Patricia Vázquez RodrígueziD, Li SuiD, Robert J. ArnoldiD, Tim D. FryeriD, Young T. Hong, Franklin I. AigbirhioiD, James Benedict RoweiD, John Tiernan O'BrieniD
Abstract
Dementia with Lewy bodies (DLB) is the second-leading degenerative dementia after Alzheimers disase. Neuropathologically, it is characterized by alpha-synuclein protein deposition with variable degree of concurrent Alzheimer pathology. Neuroinflammation is increasingly recognized as a significant contributor of degeneration.\n\nObjectiveto examine the relationship between microglial activation as measured with [11C]-PK11195 brain PET and MR diffusion tensor imaging (DTI) in DLB.\n\nMethodsnineteen clinically probable DLB and 20 similarly aged controls underwent structural MRI with T1-weighted and 3T DTI sequences. Eighteen DLB subjects also underwent [11C]-PK11195 PET imaging. Tract-Based Spatial Statistics (TBSS) were performed to compare DTI parameters in DLB relative to controls and identify associations of [11C]-PK11195 binding with white matter integrity.\n\nResultsTBSS showed widespread changes in all DTI parameters in the DLB group compared to controls (Threshold Free Cluster Enhancement (TFCE) p < 0.05). [11C]-PK11195 binding in parietal cortices also correlated with widespread lower mean and radial diffusivity (TFCE p < 0.05).\n\nConclusionOur study demonstrates that higher PK11195 binding is associated with a relative preservation of white matter, positioning neuroinflammation as a potential early marker in the DLB pathogenic cascade.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 27
- FWCI
- 1.74
- Field percentile
- top 16%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes
Naomi Hannaway, Angeliki Zarkali, … Rimona Sharon Weil·Alzheimer s & DementiaPeer-reviewed·May 1, 2025
- Grey matter microstructural alterations distinguish cognitive impairment in Lewy body diseases
Angeliki Zarkali, Ivelina Dobreva, … Rimona Sharon Weil·bioRxiv·Jan 7, 2026
- CD11b Activation Reduces Myeloid Brain Infiltration and Mitigates Synucleinopathy in a Model of Parkinson's Disease
Ameera M. Shaw, Viviana Jiménez, … Vineet Gupta·bioRxiv·Aug 11, 2025
- Neuroinflammation and functional connectivity in Alzheimer's disease: interactive influences on cognitive performance
Luca Passamonti, Kamen A. Tsvetanov, … James Benedict Rowe·Journal of NeurosciencePeer-reviewed·Jul 18, 2019
- Parkinson's disease-derived α-Synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype
Cansu Yildirim, Alexis Fenyi, … Stéphane Hunot·bioRxiv·Nov 30, 2023
- Microglial Lag3 Drives α-Synuclein--induced Neurotoxic Activated (A1) Astrocytes and Neurodegeneration
Xiuli Yang, Ramhari Kumbhar, … Xiaobo Mao·bioRxiv·Jan 6, 2026